Welcome to Francis Academic Press

International Journal of Frontiers in Medicine, 2022, 4(6); doi: 10.25236/IJFM.2022.040606.

Study on the Effects of HIF-1α on Ischemic Stroke

Author(s)

Yuehang Zhang, Jiahao Xue, Xu Deng

Corresponding Author:
​Yuehang Zhang
Affiliation(s)

Shaanxi University of Traditional Chinese Medicine, Century Avenue, Xixian New Area, Shaanxi, 712046, China

Abstract

Stroke is one of the diseases with high incidence of cardiovascular and cerebrovascular diseases in the world. Its disability rate ranks first in cardiovascular and cerebrovascular diseases. The pathophysiology of this disease is that cerebral blood circulation leads to cerebral ischemia and hypoxia, which leads to softening and necrosis of brain tissue. Hif-1 α is a nuclear transcription factor produced by the body under hypoxia, which activates a series of target genes to produce hypoxia tolerance response and maintain environmental balance in the body. Hif-1 α is a nuclear protein produced under hypoxia. By regulating downstream cells, it can promote the formation of new blood vessels, resist neuronal apoptosis, and alleviate ischemia and hypoxia injury. Hif-1 α is a key hypoxia receptor, which can be expressed rapidly in brain hypoxia, and its level is closely related to hypoxia. The role of hypoxia-inducible factor-1 α (HIF-1α) in ischemic stroke has become a research hotspot in recent years.

Keywords

Stroke, HIF-1α, Hypoxia

Cite This Paper

Yuehang Zhang, Jiahao Xue, Xu Deng. Study on the Effects of HIF-1α on Ischemic Stroke. International Journal of Frontiers in Medicine (2022), Vol. 4, Issue 6: 33-35. https://doi.org/10.25236/IJFM.2022.040606.

References

[1] Tsujio S, Chono A, Kawahira K, et al. 605 Development of function recovery training assistant system on one cerebral apoplexy paralysis leg: 2nd report: A method for calculation and evaluation of inverse kinematic [J]. Am J Prev Med, 2015, 39 (6): 605-606.

[2] Wang Longde, Liu Jianmin, Yang Yi, Peng Bin, Wang Yilong. Stroke prevention and treatment in China: An overview of the Chinese Stroke Prevention and Treatment Report 2018 [J]. Chinese journal of circulation, 2019, 34(02): 105-119.

[3] Zhang Chengfa, Wang Fuxin. 315 cases of ischemic stroke risk factors Logistic Regression analysis [J]. Heilongjiang medical science, 2015, 38 (2): 153-155.

[4] Wu Junli, Huang Wei. Enhancement of blood lipid on acute cerebral infarction and TOAST of all types Study on the influence of different types of patients [J]. Heilongjiang med sci, 2016,39 (4): 42-44.

[5] Barteczek P, Li L, Ermst AS, et al. Neuronal HIF-1 and HIF-2a deficiency improves neuronal survival and sensorimotor function in the early acute phase after ischemic stroke [J]. J Cereb Blood Flow Metab, 2017, 37(1): 291 - 306.

[6] Sun Ruixue, Jiang Hong, Zhang Ningmei, et al. Correlation analysis of serum Copeptin, HIF-1α and CT-1 levels with neonatal sepsis myocardial injury [J]. Journal of Central South Medical Science, 2019, 47(5): 462-464.

[7] Lu Linmin, Song Xuedong, Luo Ning. Diagnostic value of magnetic resonance imaging combined with serum hypoxia-induced factor-1 in neonates with hypoxic ischemic encephalopathy [J]. Medical Journal of PLA, 2018, 30(2):41-45.

[8] SemenzaGL, WangGL. A nuclear factor induced by hypoxiaviade novoprote in synthesis birds to the humanery thopoitin gene enhancer at a site required for transcripticnalactivation [J]. MDcellBio1, 1992, 12 (12): 5447-5454.

[9] Sun HD, Liu YJ, Chen J, et al. Research on the role of HIF-1 α in septic stroke induced by its subjunctive mesenteric lymph [J]. Biomed Pharmacother, 2017, 91 (1): 476-484.

[10] Xu W, Xu R, Li X, et al. Downregulating hypoxia-induc-ible factor-1 α expression with perfluorooctyl-bromide nanopar ticles Early Clinical data analysis of clinical data in rats [J]. Am J Transl Res, 2016, 8 (5): 2114 -2126

[11] Abe H, Semba H, Takeda N, et al. Role of hypoxia signaling in pathogenesis of cardiovascular diseases [J]. J Atheroscler Thromb, 2017, 24 (9): 884-894.

[12] Jeong W, Bazer FW, Song G, et al. Expression of hypoxia - inducible factor -1 by trophectoderm cells in response to hy- poxia and epidermal growth [J]. Biochem Biophys Res Commun, 2016, 469 (2): 176-182.

[13] Pan F, Barbi J, Pardoll DM. Hypoxia-inducible Factor 1: A link between differentiation and T cell differentiation and A potential therapeutic target [J]. Oncoimmunology, 2012, 1 (4): 510-515.

[14] Wu Yudan, Ni Jiayan, Chen Yaoting, et al. Effects of hiF-1 α gene silencing on the proliferation of rat hepatocellular carcinoma cells [J]. Chinese journal of pathophysiology, 2013, 29 (7):1207-1212.

[15] Semenza GL. Oxygen homeostasis [J]. Wiley Interdiscip Rev Syst Biol Med, 2010; 2 (3): 336-61.

[16] Zhang ZY, Yan JQ, Taheri S, Et al. Hypoxia-inducible factor1 contributes n-acetylcysteine's protection against stroke [J]. Free Radical Biol Med, 2014; 68 (1): 8-21.

[17] Ogle ME, Gu XH, Espinera AR, et al. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and Requires Hypoxia inducible factor-1α [J]. Neurobiol Dis, 2012; 45 (2):733-42

[18] Cheng YL, Park JS, Manzanero S, Et al. Evidence that collaboration between HIF-1α and notch-1 promotes neuronal cell death in ischemic stroke [J]. Neurobiol Dis, 2014; 62 (1): 286-95.

[19] Zhu Shaoliang, Tu Qiang, Huang Yi. Expression of HIF-1α and Ngb in patients with cerebral apoplexy [J]. Journal of clinical laboratory science, 2016, 34(07): 578-580.